+467.0%
MRNA vs RVMD
+375.0%
+92.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RVMD | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.2% | +5.2% | +5.4% |
| 7D | -1.1% | -3.0% | +1.9% | -0.7% |
| 30D | +126.1% | -0.7% | +126.8% | +125.7% |
| 3M | +190.0% | +36.5% | +153.5% | +177.7% |
| 6M | +157.2% | +104.6% | +52.6% | +135.7% |
| YTD | +388.2% | +155.8% | +232.4% | +326.3% |
| 1Y | +467.0% | +340.7% | +126.4% | +345.9% |
| All | +467.0% | +375.0% | +92.0% | +345.9% |
Cumulative growth
Daily Returns
Daily percentage return beside RVMD.
Daily Out/Under-Performance
Portfolio return minus RVMD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RVMD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RVMD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling